[go: up one dir, main page]

GR3020325T3 - Antibody antagonists of human interleukin-4 - Google Patents

Antibody antagonists of human interleukin-4

Info

Publication number
GR3020325T3
GR3020325T3 GR960401694T GR960401694T GR3020325T3 GR 3020325 T3 GR3020325 T3 GR 3020325T3 GR 960401694 T GR960401694 T GR 960401694T GR 960401694 T GR960401694 T GR 960401694T GR 3020325 T3 GR3020325 T3 GR 3020325T3
Authority
GR
Greece
Prior art keywords
binding
antagonists
antibody antagonists
receptors
human interleukin
Prior art date
Application number
GR960401694T
Other languages
English (en)
Inventor
Lata Ramanathan
Gail F Seelig
Paul P Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of GR3020325T3 publication Critical patent/GR3020325T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR960401694T 1989-12-20 1996-06-24 Antibody antagonists of human interleukin-4 GR3020325T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45357089A 1989-12-20 1989-12-20
PCT/US1990/007289 WO1991009059A1 (en) 1989-12-20 1990-12-18 Antibody antagonists of human interleukin-4

Publications (1)

Publication Number Publication Date
GR3020325T3 true GR3020325T3 (en) 1996-09-30

Family

ID=23801108

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401694T GR3020325T3 (en) 1989-12-20 1996-06-24 Antibody antagonists of human interleukin-4

Country Status (26)

Country Link
US (1) US6358509B1 (el)
EP (1) EP0506826B1 (el)
JP (1) JPH0730116B2 (el)
KR (1) KR960016862B1 (el)
AT (1) ATE136906T1 (el)
AU (1) AU639754B2 (el)
CA (1) CA2071908C (el)
CZ (1) CZ283050B6 (el)
DE (1) DE69026627T2 (el)
DK (1) DK0506826T3 (el)
ES (1) ES2085983T3 (el)
FI (1) FI104180B1 (el)
GR (1) GR3020325T3 (el)
HU (1) HU215245B (el)
IE (1) IE74708B1 (el)
IL (1) IL96714A0 (el)
MX (1) MX9203401A (el)
MY (1) MY106507A (el)
NO (1) NO922457L (el)
NZ (1) NZ236511A (el)
OA (1) OA09704A (el)
PT (1) PT96230B (el)
SK (1) SK279933B6 (el)
TW (1) TW221675B (el)
WO (1) WO1991009059A1 (el)
ZA (1) ZA9010190B (el)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714146A (en) * 1992-08-26 1998-02-03 Board Of Regents Of The University Of Washington IL-4 bone therapy
ZA946765B (en) 1993-09-02 1996-02-15 Dartmouth College Methods of prolonged suppression of humoral immunity
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
PL180125B1 (pl) * 1993-09-07 2000-12-29 Smithkline Beecham Corp Bialko fuzyjne o swoistosci wiazania przeciwko ludzkiej IL-4, PL PL PL PL PL PL
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US5705154A (en) * 1995-03-08 1998-01-06 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
WO1998037917A1 (en) * 1997-02-28 1998-09-03 Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc. Novel processes implementing selective immune down regulation (sidr)
DE69933696T2 (de) 1998-12-14 2007-08-23 Genetics Institute, LLC, Cambridge Cytokinrezeptor-kette
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US6506539B2 (en) * 2000-04-06 2003-01-14 Fuji Photo Film Co., Ltd. Dye complex and optical information recording medium
ES2382891T3 (es) 2000-05-26 2012-06-14 Immunex Corporation Uso de anticuerpos IL-4R y sus composiciones
US20020076409A1 (en) * 2000-07-12 2002-06-20 March Carl J. Method for treating cancer
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
FR2838444B1 (fr) * 2002-04-10 2016-01-01 Neovacs Nouveaux peptides et leur application en therapeutique
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
AU2003251633A1 (en) * 2002-07-01 2004-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Il-21 as a regulator of immunoglobin production
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
WO2004096849A2 (en) * 2003-04-25 2004-11-11 University Of Manitoba Peptide-based cytokine/chemokine vaccines against allergy
CA2543982C (en) 2003-11-07 2013-01-08 Immunex Corporation Antibodies that bind interleukin-4 receptor
ES2775204T3 (es) 2003-12-23 2020-07-24 Genentech Inc Nuevos anticuerpos anti IL13 y usos de los mismos
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
RU2382049C2 (ru) * 2004-08-03 2010-02-20 Новартис Аг ЧЕЛОВЕЧЕСКИЕ МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА К ЧЕЛОВЕЧЕСКОМУ ИНТЕРЛЕЙКИНУ-4 (hIL-4)
PE20060560A1 (es) * 2004-08-03 2006-06-27 Novartis Ag Anticuerpos de interleucina-4 humana
BRPI0921717A2 (pt) * 2008-11-17 2018-10-09 Kobenhavns Univ composto, sequência de peptídeo isolada, composição farmacêutica, uso de um composto, anticorpo, e, método de tratamento
KR101860963B1 (ko) 2010-04-23 2018-05-24 제넨테크, 인크. 이종다량체 단백질의 생산
US10689447B2 (en) 2011-02-04 2020-06-23 Genentech, Inc. Fc variants and methods for their production
CN103649117B (zh) 2011-02-04 2016-09-14 霍夫曼-拉罗奇有限公司 Fc变体及其生成方法
MX2015013901A (es) * 2013-04-05 2015-12-11 Genentech Inc Anticuerpos anti-il-4 y anticuerpos biespecificos y sus usos.
NZ756750A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
ES2915378T3 (es) 2013-09-13 2022-06-22 Hoffmann La Roche Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
KR20230164192A (ko) 2014-05-06 2023-12-01 제넨테크, 인크. 포유동물 세포를 사용한 이종다량체 단백질의 생산
KR102652133B1 (ko) * 2018-02-01 2024-03-29 베이징 카윈 테크놀로지 쉐어-홀딩 컴퍼니 리미티드 IL-4Rα 항체 및 그 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
ZA872781B (en) 1986-05-19 1987-10-05 Immunology Ventures B-cell stimulating factor
KR900700132A (ko) * 1988-02-02 1990-08-11 에릭 에스. 딕커 면역 글로불린 e 반응 억제 방법

Also Published As

Publication number Publication date
ATE136906T1 (de) 1996-05-15
NO922457D0 (no) 1992-06-19
OA09704A (en) 1993-08-30
US6358509B1 (en) 2002-03-19
NO922457L (no) 1992-06-19
EP0506826A1 (en) 1992-10-07
DE69026627T2 (de) 1996-08-22
CZ283050B6 (cs) 1997-12-17
JPH0730116B2 (ja) 1995-04-05
HU9202073D0 (en) 1992-09-28
SK635290A3 (en) 1999-06-11
TW221675B (el) 1994-03-11
FI922847A0 (fi) 1992-06-18
MY106507A (en) 1995-06-30
IE904589A1 (en) 1991-07-03
CZ635290A3 (en) 1997-08-13
PT96230B (pt) 1998-06-30
MX9203401A (es) 1992-07-01
FI922847L (fi) 1992-06-18
WO1991009059A1 (en) 1991-06-27
AU7176291A (en) 1991-07-18
AU639754B2 (en) 1993-08-05
IE74708B1 (en) 1997-07-30
SK279933B6 (sk) 1999-06-11
FI104180B (fi) 1999-11-30
ZA9010190B (en) 1991-08-28
EP0506826B1 (en) 1996-04-17
IL96714A0 (en) 1991-09-16
KR960016862B1 (ko) 1996-12-23
CA2071908C (en) 2002-04-30
HU215245B (hu) 1998-11-30
FI104180B1 (fi) 1999-11-30
DK0506826T3 (da) 1996-05-13
HUT64568A (en) 1994-01-28
PT96230A (pt) 1991-10-15
CA2071908A1 (en) 1991-06-21
NZ236511A (en) 1993-02-25
KR920703642A (ko) 1992-12-18
JPH04506359A (ja) 1992-11-05
DE69026627D1 (de) 1996-05-23
ES2085983T3 (es) 1996-06-16

Similar Documents

Publication Publication Date Title
IL96714A0 (en) Antibody antagonists of human interleukin-4
DK0760857T3 (da) Receptor for onkostatin M
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
DE68929384D1 (de) Therapeutische Zusammensetzungen die monoklonale Antikörper enthalten gegen den menschlichen Rezeptor für epidermalen Wachstumsfaktor
EP0573545A4 (en) MONOCLONAL ANTIBODIES AGAINST RECEPTOR - INDUCED BINDING SITES.
ES8607564A1 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
EP0575546A4 (en) Prad1 cyclin and its cdna
FI893300A7 (fi) Ihmisen B-solun pinta-antigeenille spesifinen kimeerinen vasta-aine
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
TW272197B (el)
DE3867537D1 (de) Mischung von monoklonalen antikoerpern zur bestimmung der creatinkinaseaktivitaet.
DE3684578D1 (de) Monoklonale antikoerper mit bindungsspezifitaet fuer menschliche prostatatumorantigene und methoden fuer ihre verwendung.
DE69430313D1 (de) Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
IT1220490B (it) Perfezionamento degli elementi che attrezzano il recipiente,adatto per impastare farina con altri ingredienti e per la cottura dell'impasto ottenuto
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin
IT1220467B (it) Recipiente particolarmente per uso familiare adatto:per impastare farina con altri ingredienti e per la cottura dell'impasto stesso